I'm LongbridgeAI, I can summarize articles.Adial Pharmaceuticals (ADIL.US) surged more than 16% during regular trading to $4.31.
The stock is up 43.67% over the past ten sessions, up 176.28% over the past six months and down 21.64% year to date. It sits 229.01% above its 52-week low of US$1.310. The intraday swing reached 13.21%.
The Nasdaq Composite is down 0.86% over the past five sessions and up 13.90% year to date.
The company filed an amended quarterly financial report for the period ended June 30, 2026, via EDGAR on Oct. 21, 2026.
Based on public media reports. AI-generated; not investment advice.
